Jing Wang
16Patents
5h-index
47Co-inventors
58Inventor score
Filing activity: Apr 28, 2004 → Feb 15, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7700594B2 | Fused bicyclic mTOR inhibitors | Chemistry; Metallurgy | 34 | Active |
| US7923555B2 | Fused bicyclic mTor inhibitors | Chemistry; Metallurgy | 13 | Active |
| US8314111B2 | Fused bicyclic motor inhibitors | Chemistry; Metallurgy | 12 | Active |
| US7943767B2 | Fused bicyclic mTOR inhibitors | Chemistry; Metallurgy | 7 | Active |
| US8796455B2 | Fused bicyclic mTOR inhibitors | Chemistry; Metallurgy | 6 | Active |
| US7381736B2 | Thiazole and thiadiazole inhibitors of tyrosine phosphatases | Chemistry; Metallurgy | 4 | Expired |
| US8481733B2 | Substituted imidazopyr- and imidazotri-azines | Human Necessities | 4 | Active |
| US8178668B2 | 2-aminopyridine kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7960428B2 | Enantiomerically pure phosphoindoles as HIV inhibitors | Human Necessities | 1 | Active |
| US8378104B2 | 7-aminofuropyridine derivatives | Human Necessities | 1 | Active |
| US9351974B2 | Substituted pteridinones for the treatment of cancer | Human Necessities | 1 | Active |
| US8445510B2 | Fused bicyclic kinase inhibitors | Human Necessities | 0 | Active |
| US8486991B2 | Enantiomerically pure phosphoindoles as HIV inhibitors | Human Necessities | 0 | Active |
| US7595390B2 | Industrially scalable nucleoside synthesis | Chemistry; Metallurgy | 0 | Expired |
| US8022206B2 | Furo[3,2-C]pyridines | Human Necessities | 0 | Active |
| US8592448B2 | Substituted pyrrolo[2,3-b]-pyridines and -pyrazines | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.